Lilly’s Lechleiter Puts A Smile On 2015 Guidance That Came Up Short
This article was originally published in The Pink Sheet Daily
Executive Summary
The big pharma missed analysts’ expectations for revenue and earnings in 2015, but says its strategy to focus on three therapeutic areas is paying off despite increased competition.